智通财经APP获悉，截止12月18日收盘，有36只股票创52周新高，其中广骏集团控股股权(08573)、华美 乐乐(08429)、高科桥(09963)创高率位于前3位，分别为112.12%、53.70%、32.86%。 52周新高排行 52周新低排行 | 股票名称 | 收盘价 | 最低价 | 创低率 | | --- | --- | --- | --- | | 瑞慈医疗(01526) | 0.870 | 0.710 | -17.44% | | 谊砾控股(00076) | 0.185 | 0.166 | -17.00% | | 曹操出行(02643) | 28.960 | 28.880 | -11.03% | | 景业名邦集团(02231) | 0.090 | 0.074 | -9.76% | | 民生国际(00938) | 0.330 | 0.300 | -9.09% | | 皓文控股(08019) | 0.155 | 0.155 | -8.82% | | 创梦天地(01 119) | 0.540 | 0.530 | -8.62% | | HASHKEY HLDGS(03887) | 5.630 | 5.630 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年11月30日 狀態: 新提交 本月底法定/註冊股本總額： USD 1,000,000 FF301 第 1 頁 共 10 頁 v 1.1.1 致：香港交易及結算所有限公司 公司名稱: 瑞慈醫療服務控股有限公司（本公司）（於開曼群島注冊成立的有限公司） 呈交日期: 2025年12月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01526 | 說明 | 普通股 | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 10,000,000,000 | USD | | 0.0001 USD | | 1,000,000 | | 增加 / 減少 (-) | | | | | | USD | | | | 本月底結 ...

在传统超声领域，双方还将携手打造非公医疗领域首个"人工智能超声应用联合创新中心"。 从行业情况来看，当前的传统超声领域，正处在一个技术融合与市场格局剧变的时期。"人工智能超声 应用联合创新中心"旨在攻克超声检查长期面临的操作者依赖性强、效率低等行业难题。基于此，该中 心将构建一个从"数据"到"临床"的完整创新闭环：瑞慈医疗集团将开放其覆盖多地域、多人群的海量超 声影像数据与资深医师的专家经验；联影集团则注入其在医学影像AI领域深厚的算法积累与工程化能 力，共同推动超声检查的标准化、智能化与普惠化。 双方认为，此次瑞慈医疗集团与联影集团的战略携手，超越了单一的影像设备合作，未来将在人工智 能、健康管理中心运营、治疗设备多领域全面深度交流，是一次从设备应用到临床服务模式的深度共 创；并且，双方将以此次合作为新起点，持续探索科技与医疗融合的更多可能性，共同致力于医疗质量 的提升、运营效率的突破与患者体验的革新。 （文章来源：证券时报网） "2025年是医疗大模型元年，AI新技术正快速重塑整个医疗行业，此次与联影集团的战略协同，依托联 影集团全线高端医疗装备与诊疗一体化AI，深度赋能瑞慈医疗集团未来布局与智能化升级。 ...

Core Viewpoint - 瑞慈医疗 has made a significant investment by purchasing a luxury villa in Shanghai for approximately 199 million RMB, which is a strategic move to enhance its asset portfolio amidst challenges in its core medical business [1][4]. Group 1: Investment Details - The property acquired is a villa located at Longqi Road, covering an area of approximately 570.06 square meters, with a transaction price of about 34.9 million RMB per square meter, surpassing the average recorded price of 29.8 million RMB per square meter [3][12]. - 瑞慈医疗 has paid an initial deposit of 30 million RMB, with the remaining 169 million RMB due by November 30 [3]. - This investment represents over 13.67% of 瑞慈医疗's market capitalization, which is approximately 1.56 billion RMB [4]. Group 2: Financial Context - As of June 30, 2025, 瑞慈医疗 reported cash and cash equivalents of about 1.03 billion RMB, indicating that the villa purchase significantly impacts its cash reserves [3]. - The company’s asset-liability ratio stands at 46.2%, slightly down from 46.4% at the end of 2024, while the scale of mortgaged assets has nearly doubled within six months [8][9]. - The acquisition is seen as a long-term investment opportunity, potentially providing reasonable returns due to the property's location in a core commercial area of Shanghai [4]. Group 3: Market Position and Challenges - 瑞慈医疗 is currently experiencing a revenue decline, with a 7% year-on-year decrease in revenue to 1.145 billion RMB in the first half of 2025, attributed to external competitive pressures [8]. - The company’s net profit for the same period fell by 34.18% to 55.94 million RMB, despite an increase in gross margin from 32.2% to 35.6% [8]. - The decision to invest in prime real estate reflects a strategy to diversify and maintain cash flow amid pressures from medical insurance cost control and market competition [9].

Core Insights - The recent purchase of luxury properties by companies like 瑞慈医疗 and 嘉里建设 highlights the ongoing strength of the high-end real estate market in Shanghai, despite a broader industry downturn [2][6][8] - 瑞慈医疗's acquisition of a villa for approximately 1.99 billion yuan reflects a strategic long-term investment in a prime location, indicating confidence in future capital appreciation [3][4] - 嘉里建设's purchase of a property for 1.17 billion yuan and the subsequent strong sales performance of its 金陵华庭 project demonstrate robust demand for luxury housing in Shanghai [6][7] Company Actions - 瑞慈医疗's indirect subsidiary, 上海瑞慈瑞铂门诊部有限公司, purchased a residential unit in 云锦东方, with a total area of about 570.06 square meters at a price of 34.9 million yuan per square meter [3][4] - 嘉里建设's chairman, 郭孔华, acquired a 449 square meter unit in 金陵华庭 for 1.17 billion yuan, with expectations of generating approximately 23 million yuan in profit from the transaction [6][7] Market Trends - The luxury real estate market in Shanghai is experiencing significant growth, with high-end properties priced over 50 million yuan seeing a 27% increase in transactions year-on-year [2][8] - In the first three quarters of 2025, luxury properties accounted for nearly 80% of total transactions in 11 major cities across China, indicating a strong preference for high-value assets [8] - The recent sales performance of 金陵华庭, which sold out quickly at high prices, reflects a strong demand for luxury housing driven by affluent buyers seeking core assets [7][8]

Core Viewpoint - 瑞慈医疗 has made a strategic investment by purchasing a luxury residential unit in Shanghai, viewing it as a long-term investment opportunity in a prime location with significant growth potential [1][2]. Company Summary - 瑞慈医疗's subsidiary, Shanghai Ruici Ruibo Outpatient Department Co., Ltd., acquired a residential unit for approximately 199 million yuan, with a total area of about 570.06 square meters [1]. - The company has paid a deposit of 30 million yuan, with the remaining 169 million yuan to be settled by November 30 [1]. - The purchased property is part of the Yun Jin Dong Fang project, which has seen high demand due to its luxury status and celebrity residents [1]. Industry Summary - The Shanghai real estate market has experienced a contraction in supply, with new housing supply decreasing by approximately 19% year-on-year to 1.3156 million square meters in the third quarter [4]. - Despite the reduced supply, the overall average price of new homes in Shanghai has increased by about 8.5% year-on-year, driven by the entry of luxury properties and relaxed price controls [4]. - The market is shifting towards a more normalized sales environment, with a recovery in the absorption rate to around 80% in core areas, indicating a potential upward trend in property prices due to various factors such as industrial development and population influx [5].

Group 1 - The core viewpoint of the news is that Ruici Medical has made a strategic investment by purchasing a luxury residential unit in Shanghai, indicating confidence in the long-term capital appreciation potential of the property market in the city [1][2][4] - Ruici Medical's subsidiary, Shanghai Ruici Ruibo Clinic, acquired a residential unit for approximately 199 million yuan, with a total area of about 570.06 square meters, reflecting a price of 349,000 yuan per square meter [1][4] - The property is located in the prestigious Yunjin Dongfang project, which has seen significant demand due to its high-profile celebrity residents and the overall market trend of rising prices despite a contraction in new housing supply [1][4][5] Group 2 - The company views this acquisition as a favorable medium to long-term investment, benefiting from Shanghai's status as a major economic and financial hub with substantial growth potential [2][4] - The Shanghai real estate market has experienced a decrease in new housing supply by approximately 19% year-on-year, yet the overall average price has increased by about 8.5% due to the concentration of luxury properties entering the market [4][5] - The market is shifting towards a more normalized sales environment, with core areas seeing a recovery in sales rates to around 80%, indicating a potential upward trend in property prices driven by new luxury developments [5]

Core Viewpoint - 瑞慈医疗 has made a strategic investment by purchasing a luxury residential unit in Shanghai, viewing it as a long-term investment opportunity in a prime location with significant growth potential [2][3]. Company Summary - 瑞慈医疗's indirect wholly-owned subsidiary, Shanghai Ruici Ruibo Clinic Co., Ltd., has acquired a residential unit for approximately 199 million yuan, with a total area of about 570.06 square meters [1]. - The company has paid a deposit of 30 million yuan, with the remaining 169 million yuan to be settled by November 30, funded through internal resources [1]. - The purchased property is part of the high-end residential project, 云锦东方, which has seen increased demand due to its location and celebrity residents [1]. Industry Summary - The Shanghai real estate market has experienced a contraction in new housing supply, with a year-on-year decrease of about 19% in supply area during the third quarter [3]. - Despite the reduced supply, the overall average price of new homes in Shanghai has increased by approximately 8.5% year-on-year, driven by the entry of luxury properties and relaxed price controls [3]. - The market is shifting towards a more normalized sales environment, with core areas benefiting from resource aggregation and high-quality products, leading to a recovery in sales rates to about 80% [3].

Core Viewpoint - 瑞慈医疗 announced the purchase of a residential property in Shanghai for a total consideration of RMB 200 million, indicating strategic expansion in the real estate sector [1] Group 1: Transaction Details - The buyer, Shanghai Ruici Ruibo Outpatient Department Co., Ltd., is a wholly-owned subsidiary of 瑞慈医疗 [1] - The seller, Shanghai Eastern Airlines Real Estate Co., Ltd., is an independent third party [1] - The property is located at Longqi Road, Shanghai, with a total construction area of approximately 570.06 square meters [1]

Core Viewpoint - 瑞慈医疗 plans to acquire a residential unit in Shanghai for approximately RMB 199 million, viewing the purchase as a favorable long-term investment opportunity [1] Group 1: Acquisition Details - The acquisition involves a residential unit located at 377 Longqi Road, Shanghai, with a total construction area of approximately 570.06 square meters [1] - The buyer is Shanghai Ruici Ruibo Outpatient Department Co., Ltd., a wholly-owned subsidiary of 瑞慈医疗 [1] Group 2: Strategic Rationale - The board believes the acquisition represents a good long-term investment due to the property's location in Xuhui District, a core commercial and residential area of Shanghai [1] - Shanghai is recognized as an international hub for economy, finance, trade, logistics, and technological innovation, providing a favorable investment environment [1] - The board is optimistic about the capital appreciation potential of the property, considering surrounding development projects and the overall growth of Shanghai [1]